Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs JPMorgan Diversified Return International Eqty ETF (JPIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs JPMorgan Diversified Return International Eqty ETF — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.3 (market cap $4.02B), while JPMorgan Diversified Return International Eqty ETF trades at $73 (market cap $380.28M). The key difference: Edgewise Therapeutics Inc. Common Stock is far larger — about 10.6× JPMorgan Diversified Return International Eqty ETF's market cap, and JPMorgan Diversified Return International Eqty ETF is more actively traded (4,689 versus 1,446,128). Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and JPMorgan Diversified Return International Eqty ETF for 121 Days on average.
| EWTX | JPIN | |
|---|---|---|
Market Cap | $4.02B | $380.28M |
Volume | 1,446,128 | 4,689 |
Sector | Health | — |
52-Week High | $48.35 | $77.80 |
52-Week Low | $14.89 | $65.86 |
Typical Hold Time | 0 Days | 121 Days |
Enterprise Value | $3.56B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JPIN trades at $73.52, up 0.65% with bearish technical signals dominating. The ETF shows oversold RSI readings but faces strong selling pressure across moving averages and ADX indicators. Support and resistance cluster tightly around $73-74, suggesting potential for near-term volatility. Recent dividend announcement for September 2026 provides future income potential.
The ETF's outlook remains challenged by bearish momentum despite oversold conditions. Investment opportunity exists for value investors seeking international equity exposure, though risks include continued technical weakness and market volatility. The concentrated price action around current levels indicates potential breakout or breakdown scenario ahead.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About JPMorgan Diversified Return International Eqty ETF
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →
